NEW YORK

David Brennan, CEO of AstraZeneca Plc

AstraZeneca shares plunging on approval delay of heart drug

Shares of U.K. drugmaker AstraZeneca PLC (NYSE: AZN) are plunging after the U.S. Food and Drug Administration requested further analysis of existing studies of the company’s heart drug, Brilinta, thereby further delaying its potential approval.
More news
George Canellos, Director of the SEC's New York Regional Office, speaks  in New York, March 2, 2010.

Lawyer charged in investment scam

The lawyer for indicted former financial adviser Kenneth Starr was himself charged today for assisting in Starr's multi-million dollar fraud, the Securities and Exchange Commission said.
A woman walks out of AOL offices in New York

AOL expands advertising offering, buys Pictela

AOL Inc. announced its acquisition of New York-based content marketing platform startup Pictela to bolster its advertising offering. Terms of the deal were not disclosed. Pictela is a platform for distributing videos, photos and applications across the Web in real time.
Intelligence reports paint gloomy picture of Afghanistan ahead of Obama's review

Intelligence paints gloomy Afghan picture ahead of Obama's review

The war in Afghanistan is unlikely to be won, US Intelligence reports suggest. Even as President Barack Obama is all set to announce policy review on the war in Afghanistan, two classified reports state that it could be improbable to end Taliban and Al Qaeda insurgency in the Tribal regions of the country. The reports however, have fueled a bitter row between the intelligence agencies and the military over who has a better perspective and proximity in the war zone.
A GM sign is seen outside the Medved General Motors car dealership in Arvada, Colorado

GM repays $2.1 bln to US tax payers

General Motors has paid $2.1 billion to complete the repurchase of preferred shares issued under a federal government bailout, the U.S. Treasury said on Wednesday. With this the auto maker has brought the total sum recouped by taxpayers to more than 23 billion dollars.
Goldman Sachs

2010 could become Wall Street’s second most profitable year ever

In spite of a fragile U.S. economy, 2010 could end up the second most profitable year for New York City’s securities industry, with the average Wall Street bonus topping last year’s figure due to fewer workers and high earnings, according to a report by the State Comptroller of New York.
Novartis AG headquarters in Basel, Switzerland

Novartis Clinches Alcon In $12.9 Bln Deal

Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
IBTimes Logo

Australian dollar off parity vs greenback on profit booking

The Australian dollar that rose above parity on Tuesday helped by renewed risk appetite after the US Fed's decision to keep its accommodative policy intact for an extended period of time, but was down across the board in Asian trade on Wednesday as investors booked profit.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.